ECIL Guidelines for Treatment of Pneumocystis Jirovecii Pneumonia in Non-HIV-Infected Haematology Patients

This is a clinical practice guideline for non-HIV-infected hematology patients. The guideline examines the treatment of Pneumocystis jirovecii pneumonia (PCP) in these patients. First-line treatment including selection of drugs and route of administration is discussed, as well as assessment of treatment response, second-line treatment, drug-related side-effects and drug-drug interactions, treatment duration, intensive care, glucocorticosteroids as adjuvant therapy, and secondary anti-PCP prophylaxis. The symptoms of PCP in hematology patients, criteria for initiation of PCP treatment, and grading of PCP severity and prognostic factors are also addressed.